Instrument Inactif

Autres langues Innovate Biopharmaceuticals Inc Nasdaq

Actions

North American Morning Briefing : Tech in Focus on -2-	25/03
Bidding Procedure Approved for 9 Meters Biopharma, Inc.	29/11
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	27/11
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	07/11
North American Morning Briefing : Stocks Look to -2-	06/11
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	02/11
Celiac Disease Pipeline, Clinical Trials, FDA Approvals, and Emerging Drugs 2023 (Updated)	02/10/23
North American Morning Briefing : Stock Futures -2-	22/09/23
North American Morning Briefing : Mood Seen Buoyed -2-	15/09/23
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	08/09/23
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown	01/09/23
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	25/08/23
North American Morning Briefing : China Trouble Hits Sentiment	18/08/23
North American Morning Briefing : Stock Futures -2-	11/08/23
Illumina cuts annual profit forecast as biotech funding woes linger	09/08/23
Illumina cuts annual profit forecast	09/08/23
9 Meters Biopharma, Inc.(OTCPK:NMTR.Q) dropped from NASDAQ Composite Index	25/07/23
9 Meters Biopharma, Inc.(NasdaqCM:NMTR) dropped from S&P TMI Index	21/07/23
Drug developer 9 Meters Biopharma files for bankruptcy protection	18/07/23
9 Meters Biopharma, Inc. Filed for Bankruptcy	17/07/23

Aucun résultat pour cette recherche